Tony Rowe

Tony has over twenty years of experience in the biopharmaceutical industry in the US and Australia, including as a research scientist at Biogen Idec and Arana Therapeutics focusing on the discovery and early stage development of biologics in multiple therapeutic areas. He holds a PhD in biochemistry and molecular biology from the University of Cambridge (UK) and completed post-doctoral studies in cell biology at the Scripps Research Institute (US).

​Tony is currently an Associate Director in the Project Management group at CSL where his primary role is to lead teams engaged in the progression of monoclonal antibody and recombinant protein therapeutic candidates from Research into the Development stage. He has worked on the P. gingivalis vaccine program in collaboration with Prof Reynolds and colleagues since joining CSL in early 2010 and is seconded on a part-time basis to Denteric.